Supplementary Figure S1 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer | Synapse
September 16, 2024
Supplementary Figure S1 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Frequency of patients with long-term response (LTR), short-term response (STR), and progressive disease (PD) from individual clinical sites.
AI에게 질문
Like
Bookmark
Share
Cite This Study
Thummalapalli et al. (Mon,) studied this question.